Tina Ventura | SVP, IR |
Timothy Walbert | Chairman, President & CEO |
Elizabeth Thompson | Group Vice President, Clinical Development and External Search |
Paul Hoelscher | EVP & CFO |
Andy Pasternak | EVP & Chief Strategy Officer |
Kenneth Cacciatore | Cowen and Company |
Annabel Samimy | Stifel, Nicolaus & Company |
David Amsellem | Piper Sandler & Co. |
Christopher Schott | JPMorgan Chase & Co. |
David Risinger | Morgan Stanley |
David Steinberg | Jefferies |
Jason Gerberry | Bank of America Merrill Lynch |
Dana Flanders | Guggenheim Securities |
Gary Nachman | BMO Capital Markets |
Good morning, and thank you for standing by, and welcome to the Horizon Therapeutics plc Third Quarter 2020 Earnings Conference Call.
As a reminder, today's conference is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations. Please go ahead.